Financhill
Buy
60

KVUE Quote, Financials, Valuation and Earnings

Last price:
$21.19
Seasonality move :
-3.26%
Day range:
$21.00 - $21.29
52-week range:
$19.75 - $25.17
Dividend yield:
3.88%
P/E ratio:
28.65x
P/S ratio:
2.70x
P/B ratio:
3.79x
Volume:
16.1M
Avg. volume:
19.9M
1-year change:
-1.72%
Market cap:
$40.7B
Revenue:
$15.5B
EPS (TTM):
$0.74

Analysts' Opinion

  • Consensus Rating
    Kenvue has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 12 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $22.80, Kenvue has an estimated upside of 7.55% from its current price of $21.20.
  • Price Target Downside
    According to analysts, the lowest downside price target is $19.00 representing 100% downside risk from its current price of $21.20.

Fair Value

  • According to the consensus of 15 analysts, Kenvue has 7.55% upside to fair value with a price target of $22.80 per share.

KVUE vs. S&P 500

  • Over the past 5 trading days, Kenvue has underperformed the S&P 500 by -0.65% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Kenvue does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Kenvue revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Kenvue reported revenues of $3.8B.

Earnings Growth

  • Kenvue has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Kenvue reported earnings per share of $0.22.
Enterprise value:
48.4B
EV / Invested capital:
2.48x
Price / LTM sales:
2.70x
EV / EBIT:
18.23x
EV / Revenue:
3.19x
PEG ratio (5yr expected):
0.26x
EV / Free cash flow:
29.72x
Price / Operating cash flow:
25.10x
Enterprise value / EBITDA:
14.83x
Gross Profit (TTM):
$8.8B
Return On Assets:
5.36%
Net Income Margin (TTM):
9.37%
Return On Equity:
13.83%
Return On Invested Capital:
7.46%
Operating Margin:
19.59%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-06-30 2024-06-30 2025-06-30 2024-06-30 2025-06-30
Income Statement
Revenue $15.4B $15.5B $15.1B $4B $3.8B
Gross Profit $8.5B $8.9B $8.8B $2.4B $2.3B
Operating Income $3B $2.9B $2.7B $716M $752M
EBITDA $3.6B $3.5B $3.3B $857M $894M
Diluted EPS $0.27 $0.35 $0.74 $0.03 $0.22
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Balance Sheet
Current Assets -- -- $6.2B $5.9B $5.9B
Total Assets -- -- $27.5B $26.4B $27.1B
Current Liabilities -- -- $5.3B $5.9B $6B
Total Liabilities -- -- $16.5B $16.3B $16.4B
Total Equity -- -- $11B $10.2B $10.7B
Total Debt -- -- $8.6B $8.6B $8.7B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-06-30 2024-06-30 2025-06-30 2024-06-30 2025-06-30
Cash Flow Statement
Cash Flow Operations $2.9B $2.4B $2.1B $440M $621M
Cash From Investing -$393M -$607M -$445M -$85M -$90M
Cash From Financing -$2.1B -$1.9B -$1.6B -$490M -$548M
Free Cash Flow $2.5B $1.8B $1.6B $350M $533M
KVUE
Sector
Market Cap
$40.7B
$219M
Price % of 52-Week High
84.23%
74.14%
Dividend Yield
3.88%
0%
Shareholder Yield
4.57%
2.74%
1-Year Price Total Return
-1.72%
-9.69%
Beta (5-Year)
--
0.378
Dividend yield:
3.88%
Annualized payout:
$0.81
Payout ratio:
-110.79%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $21.45
200-day SMA
Sell
Level $22.42
Bollinger Bands (100)
Sell
Level 21.35 - 23.49
Chaikin Money Flow
Sell
Level -9.5M
20-day SMA
Sell
Level $21.87
Relative Strength Index (RSI14)
Sell
Level 44.24
ADX Line
Sell
Level 25.9
Williams %R
Neutral
Level -76.7802
50-day SMA
Sell
Level $21.56
MACD (12, 26)
Buy
Level 5.20
25-day Aroon Oscillator
Sell
Level -56
On Balance Volume
Sell
Level -89.3M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.4691)
Buy
CA Score (Annual)
Level (-0.2932)
Buy
Beneish M-Score (Annual)
Level (-2.4453)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (0.1673)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Stock Forecast FAQ

In the current month, KVUE has received 3 Buy ratings 12 Hold ratings, and 0 Sell ratings. The KVUE average analyst price target in the past 3 months is $22.80.

  • Where Will Kenvue Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Kenvue share price will rise to $22.80 per share over the next 12 months.

  • What Do Analysts Say About Kenvue?

    Analysts are divided on their view about Kenvue share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kenvue is a Sell and believe this share price will drop from its current level to $19.00.

  • What Is Kenvue's Price Target?

    The price target for Kenvue over the next 1-year time period is forecast to be $22.80 according to 15 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 12 analysts rate the stock a Hold.

  • Is KVUE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Kenvue is a Hold. 12 of 15 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of KVUE?

    You can purchase shares of Kenvue via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kenvue shares.

  • What Is The Kenvue Share Price Today?

    Kenvue was last trading at $21.19 per share. This represents the most recent stock quote for Kenvue. Yesterday, Kenvue closed at $21.20 per share.

  • How To Buy Kenvue Stock Online?

    In order to purchase Kenvue stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is NXP Semiconductors Undervalued?
Is NXP Semiconductors Undervalued?

NXP Semiconductors (NASDAQ:NXPI) is a large European semiconductor business that…

Is Intel Stock Undervalued?
Is Intel Stock Undervalued?

In Q2 2025, Intel reported $12.9 billion in revenue, which…

Is Sinclair Stock a Short?
Is Sinclair Stock a Short?

If you strip away the buzzwords, Sinclair’s business is still…

Stock Ideas

Buy
71
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Alerts

Sell
48
NEGG alert for Aug 16

Newegg Commerce [NEGG] is down 21.62% over the past day.

Sell
35
SEDG alert for Aug 16

Solaredge Technologies [SEDG] is up 17.26% over the past day.

Buy
62
NUTX alert for Aug 16

Nutex Health [NUTX] is down 16.44% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock